Dr. Tzachanis on the Likelihood of Cure With CAR T-Cell Therapy in Lymphoma

Dimitrios Tzachanis, MD, PhD, hematologist/medical oncologist and assistant professor of medicine, University of California, San Diego Health, discusses the likelihood of cure with CAR-T cell therapy in lymphoma.

According to Tzachanis, it is difficult to definitively say that a patient is cured from their cancer.

However, since diffuse large B-cell lymphoma and acute lymphoblastic leukemia are fast-growing diseases, patients who derive at least 2-year remissions with CAR T-cell therapy may be effectively cured, concludes Tzachanis.